Safety and Efficacy of T-DM1 Plus Neratinib in Patients with Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10Jame Abraham,Albert J. Montero,Rachel C. Jankowitz,Mohamad Adham Salkeni,Jan H. Beumer,Brian F. Kiesel,Fanny Piette,Laura M. Adamson,Rebecca J. Nagy,Richard B. Lanman,Jeff Sperinde,Weidong Huang,Carmen J. Allegra,Ashok Srinivasan,Ying Wang,Katherine L. Pogue-Geile,Peter C. Lucas,Samuel A. JacobsJournal of Clinical Oncology（2019）引用 68|浏览130AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
